News Image

Why NASDAQ:GILD qualifies as a good dividend investing stock.

By Mill Chart

Last update: May 9, 2024

GILEAD SCIENCES INC (NASDAQ:GILD) was identified as a stock worth exploring by dividend investors by our stock screener. NASDAQ:GILD scores well on profitability, solvency and liquidity. At the same time it seems to pay a decent dividend. We'll explore this a bit deeper below.

Evaluating Dividend: NASDAQ:GILD

ChartMill assigns a Dividend Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing various dividend elements, such as yield, historical performance, dividend growth, and sustainability. NASDAQ:GILD has been awarded a 7 for its dividend quality:

  • With a Yearly Dividend Yield of 4.71%, GILD is a good candidate for dividend investing.
  • GILD's Dividend Yield is rather good when compared to the industry average which is at 24.55. GILD pays more dividend than 98.80% of the companies in the same industry.
  • GILD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
  • GILD has paid a dividend for at least 10 years, which is a reliable track record.
  • GILD has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.

Assessing Health for NASDAQ:GILD

ChartMill utilizes a Health Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of liquidity and solvency ratios, both in absolute terms and in comparison to industry peers. NASDAQ:GILD has earned a 5 out of 10:

  • Looking at the Altman-Z score, with a value of 2.57, GILD is in the better half of the industry, outperforming 73.50% of the companies in the same industry.
  • GILD has a debt to FCF ratio of 3.37. This is a good value and a sign of high solvency as GILD would need 3.37 years to pay back of all of its debts.
  • GILD has a Debt to FCF ratio of 3.37. This is amongst the best in the industry. GILD outperforms 95.38% of its industry peers.

Understanding NASDAQ:GILD's Profitability

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:GILD has achieved a 7:

  • The Return On Assets of GILD (9.12%) is better than 96.75% of its industry peers.
  • GILD's Return On Equity of 24.81% is amongst the best of the industry. GILD outperforms 98.12% of its industry peers.
  • The Return On Invested Capital of GILD (12.62%) is better than 97.27% of its industry peers.
  • The Profit Margin of GILD (20.89%) is better than 97.78% of its industry peers.
  • The Operating Margin of GILD (29.51%) is better than 98.29% of its industry peers.
  • The Gross Margin of GILD (76.04%) is better than 85.98% of its industry peers.

Every day, new Best Dividend stocks can be found on ChartMill in our Best Dividend screener.

For an up to date full fundamental analysis you can check the fundamental report of GILD

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

GILEAD SCIENCES INC

NASDAQ:GILD (5/17/2024, 7:01:44 PM)

After market: 67.58 -0.14 (-0.21%)

67.72

-0.14 (-0.21%)

GILD News

News Image13 hours ago - PRLogThe P3 App: Empowering and Elevating Underprivileged Youth from Socioeconomically Disadvantaged Areas Through Innovative Mentorship

CHICAGO - May 18, 2024 - PRLog -- The Pulse of Perseverance alongside Gilead is proud to announce the launch of the P3 mobile app, a pioneering platform unveiled at our signature benefit event on May 16, now available on the app store. Designed to transform the landscape of mentorship, the P3 app connects students from underprivileged backgrounds with mentors in underrepresented fields, fostering a supportive community and opening doors to internships and career opportunities.Amidst the backdrop of systemic barriers that often hinder the academic and professional aspirations of Black children, the P3 app stands as a beacon of hope and opportunity. It not only bridges the gap in resource access but also challenges the status quo by providing a direct funnel to success in advanced fields where youth from socioeconomically disadvantaged areas are vastly underrepresented.Features of the P3 App:

News Image17 hours ago - Gilead Sciences, Inc.Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
News Image2 days ago - InvestorPlacePenny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch

Penny stocks to buy understandably offers many enticing attributes, not least of which is the potential for tremendous returns.

News Image4 days ago - Market News VideoSee Which Of The Latest 13F Filers Holds Gilead Sciences
News Image5 days ago - Gilead Sciences, Inc.Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
News Image6 days ago - Yahoo FinanceOne stock is dragging down the S&P 500's earnings growth

S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.

News Image9 days ago - Gilead Sciences, Inc.Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
News Image10 days ago - InvestorPlaceBiotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine

These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot.

News Image10 days ago - ChartmillWhy NASDAQ:GILD qualifies as a good dividend investing stock.

Why GILEAD SCIENCES INC (NASDAQ:GILD) is a Top Pick for Dividend Investors.

News Image10 days ago - Market News VideoNoteworthy Wednesday Option Activity: GILD, BKNG, TGNA
News Image12 days ago - Gilead Sciences, Inc.Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
News Image13 days ago - InvestorPlaceBargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back

If you want your shot at significant upside, speculate on these stocks near 52-week lows that can prove the critics wrong.

GILD Links
Follow us for more